LRRC37B

gene
On this page

Summary

LRRC37B (leucine rich repeat containing 37B, HGNC:29070) is a protein-coding gene on chromosome 17q11.2, encoding Leucine-rich repeat-containing protein 37B (Q96QE4). It is a selective cancer dependency (DepMap: 37.3% of cell lines).

Predicted to be located in membrane.

Source: NCBI Gene 114659 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 173 total — 1 pathogenic
  • Cancer dependency (DepMap): dependent in 37.3% of screened cell lines
  • MANE Select transcript: NM_001321350

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29070
Approved symbolLRRC37B
Nameleucine rich repeat containing 37B
Location17q11.2
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000185158
Ensembl biotypeprotein_coding
OMIM616558
Entrez114659

Gene structure

Transcript identifiers

Ensembl transcripts: 23 — 11 protein_coding, 8 retained_intron, 3 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000341671, ENST00000543378, ENST00000578118, ENST00000578674, ENST00000579094, ENST00000579206, ENST00000579766, ENST00000580303, ENST00000580871, ENST00000581086, ENST00000581370, ENST00000581786, ENST00000582117, ENST00000582815, ENST00000583204, ENST00000583342, ENST00000583758, ENST00000584368, ENST00000902794, ENST00000902795, ENST00000902796, ENST00000935425, ENST00000941835

RefSeq mRNA: 2 — MANE Select: NM_001321350 NM_001321350, NM_052888

CCDS: CCDS32609, CCDS82102

Canonical transcript exons

ENST00000543378 — 15 exons

ExonStartEnd
ENSE000015193313205326632053487
ENSE000022113063202139332022825
ENSE000022416633202069732020803
ENSE000022654143201797232018054
ENSE000026919093200738332008132
ENSE000034582383203137832031458
ENSE000035243793203556532035639
ENSE000035652523205000332050107
ENSE000035790703204776132047901
ENSE000036082203204570032045818
ENSE000036092033203065632030727
ENSE000036295113202471132024782
ENSE000036609953204910232049394
ENSE000036697853202776932027840
ENSE000036913723203491032034981

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 96.23.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.1040 / max 123.6226, expressed in 1717 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1602188.04381717
1602190.060210

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cerebellar cortexUBERON:000212996.23gold quality
cerebellar hemisphereUBERON:000224596.22gold quality
cerebellumUBERON:000203796.18gold quality
ventricular zoneUBERON:000305396.10gold quality
right hemisphere of cerebellumUBERON:001489095.94gold quality
cortical plateUBERON:000534395.81gold quality
ganglionic eminenceUBERON:000402393.98gold quality
corpus callosumUBERON:000233693.75gold quality
left testisUBERON:000453392.10gold quality
right testisUBERON:000453492.07gold quality
primary visual cortexUBERON:000243691.73gold quality
pituitary glandUBERON:000000791.40gold quality
testisUBERON:000047391.34gold quality
Ammon’s hornUBERON:000195491.26gold quality
sural nerveUBERON:001548891.06gold quality
brainUBERON:000095590.88gold quality
amygdalaUBERON:000187690.84gold quality
nucleus accumbensUBERON:000188290.84gold quality
right uterine tubeUBERON:000130290.80gold quality
left ovaryUBERON:000211990.76gold quality
temporal lobeUBERON:000187190.75gold quality
right frontal lobeUBERON:000281090.72gold quality
superior frontal gyrusUBERON:000266190.62gold quality
caudate nucleusUBERON:000187390.59gold quality
adenohypophysisUBERON:000219690.54gold quality
Brodmann (1909) area 9UBERON:001354090.43gold quality
granulocyteCL:000009490.33gold quality
putamenUBERON:000187490.33gold quality
lower esophagus mucosaUBERON:003583490.31gold quality
ovaryUBERON:000099290.24gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-7303no179.62
E-MTAB-7381no50.11
E-ANND-3no4.50

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

30 targeting LRRC37B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AQ-5P99.9471.343426
HSA-MIR-548AR-5P99.9471.283515
HSA-MIR-548AU-5P99.9471.243488
HSA-MIR-548AY-5P99.9471.233502
HSA-MIR-548B-5P99.9471.233502
HSA-MIR-548BB-5P99.9471.273509
HSA-MIR-548C-5P99.9471.243488
HSA-MIR-548D-5P99.9471.233502
HSA-MIR-548H-5P99.9471.243488
HSA-MIR-548O-5P99.9471.243488
HSA-MIR-548W99.9471.243488
HSA-MIR-548Y99.9471.283514
HSA-MIR-548D-3P99.8770.674362
HSA-MIR-548BB-3P99.8670.584354
HSA-MIR-548AC99.8470.774351
HSA-MIR-548H-3P99.8470.804349
HSA-MIR-548Z99.8470.804349
HSA-MIR-5571-5P99.4966.991764
HSA-MIR-397399.2069.191990
HSA-MIR-6512-5P98.7669.291195
HSA-MIR-3928-3P97.6166.531096

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 37.3% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 1)

  • LRRC37B is a human modifier of voltage-gated sodium channels and axon excitability in cortical neurons. (PMID:38134874)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
mus_musculusLrrc37ENSMUSG00000034239
mus_musculusLrrc37aENSMUSG00000078632
rattus_norvegicusLrrc37aENSRNOG00000042025
rattus_norvegicusPrp2l1ENSRNOG00000042833

Paralogs (3): LRRC37A (ENSG00000176681), LRRC37A3 (ENSG00000176809), LRRC37A2 (ENSG00000238083)

Protein

Protein identifiers

Leucine-rich repeat-containing protein 37BQ96QE4 (reviewed: Q96QE4)

Alternative names: C66 SLIT-like testicular protein

All UniProt accessions (7): Q96QE4, F5H5K1, J3KTP0, J3QKM3, J3QL10, J3QLE7, J3QLI7

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Isoforms (2)

UniProt IDNamesCanonical?
Q96QE4-11yes
Q96QE4-22

RefSeq proteins (2): NP_001308279, NP_443120 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001611Leu-rich_rptRepeat
IPR003591Leu-rich_rpt_typical-subtypRepeat
IPR015753LRRC37Family
IPR029423LRRC37AB_CDomain
IPR032675LRR_dom_sfHomologous_superfamily
IPR032754LRRC37_NDomain

Pfam: PF13855, PF14914, PF15779

UniProt features (32 total): sequence conflict 9, repeat 6, region of interest 4, compositionally biased region 4, topological domain 2, glycosylation site 2, signal peptide 1, chain 1, coiled-coil region 1, splice variant 1, transmembrane region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96QE4-F153.350.18

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Glycosylation sites (2): 358, 789

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 42 (showing top): GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP, chr17q11, KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3, ZWANG_DOWN_BY_2ND_EGF_PULSE, CDC5L_TARGET_GENES, TFEB_TARGET_GENES, ZBTB1_TARGET_GENES, ZNF184_TARGET_GENES, ZNF2_TARGET_GENES, ZNF274_TARGET_GENES, ZNF33A_TARGET_GENES, ZNF410_TARGET_GENES, ZSCAN30_TARGET_GENES, MIR548D_3P, MIR548H_3P_MIR548Z

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1
cellular anatomical structure1

Protein interactions and networks

STRING

210 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
LRRC37BCRLF3Q8IUI8723
LRRC37BUTP6Q9NYH9719
LRRC37BADAP2Q9NPF8691
LRRC37BRAB11FIP4Q86YS3664
LRRC37BATAD5Q96QE3650
LRRC37BTEFMQ96QE5624
LRRC37BCOPRSQ9NQ92623
LRRC37BEVI2AP22794580
LRRC37BRNF135Q8IUD6571
LRRC37BEVI2BP34910507
LRRC37BSUZ12Q15022479
LRRC37BNF1P21359445
LRRC37BNPIPB6E9PJ23406
LRRC37BTMEM255BQ8WV15380
LRRC37BOMGP23515348

IntAct

4 interactions, top by confidence:

ABTypeScore
LRRC37BCFTRpsi-mi:“MI:0915”(physical association)0.370
NEK4E2F8psi-mi:“MI:0914”(association)0.350
LRRC37BHLA-Fpsi-mi:“MI:0914”(association)0.350

BioGRID (7): LRRC37B (Affinity Capture-RNA), LRRC37B (Affinity Capture-MS), HLA-F (Affinity Capture-MS), METAP2 (Affinity Capture-MS), MAN2A2 (Affinity Capture-MS), LRRC37B (PCA), LRRC37B (Affinity Capture-RNA)

ESM2 similar proteins: A0A1B0GUW6, A1EGX6, A6NM11, A6NMS7, A6QLF8, D3YU32, I3L273, J3KML8, O35930, O60309, Q08DY0, Q14242, Q2TBI7, Q32KG4, Q32L62, Q3MIW9, Q3TNW5, Q3V0E1, Q4R729, Q5VWK0, Q5VYM1, Q62170, Q659K0, Q68DN1, Q6AZ54, Q6MG22, Q6UXB8, Q6ZRG5, Q8BUE7, Q8K4E0, Q8N307, Q8N3K9, Q8TCU4, Q8WNU4, Q8WXI7, Q95JY5, Q96F05, Q96JA4, Q96M34, Q96M43

Diamond homologs: A6NM11, A6NMS7, O60309, Q49AS3, Q96QE4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

173 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance134
Likely benign19
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
981056GRCh37/hg19 17q11.2-12(chr17:29989741-32355632)Pathogenic

SpliceAI

1548 predictions. Top by Δscore:

VariantEffectΔscore
17:32024781:CT:Cdonor_gain1.0000
17:32024783:G:GGdonor_gain1.0000
17:32027841:G:GGdonor_gain1.0000
17:32027845:G:GGdonor_gain1.0000
17:32030728:G:GGdonor_gain1.0000
17:32031455:ACTT:Adonor_gain1.0000
17:32031456:CTT:Cdonor_gain1.0000
17:32031459:G:GGdonor_gain1.0000
17:32034901:A:AGacceptor_gain1.0000
17:32034904:TTTCA:Tacceptor_loss1.0000
17:32034905:TTCAG:Tacceptor_loss1.0000
17:32034906:TCA:Tacceptor_loss1.0000
17:32034907:CAG:Cacceptor_loss1.0000
17:32034908:A:ACacceptor_loss1.0000
17:32034908:A:AGacceptor_gain1.0000
17:32034909:G:GAacceptor_gain1.0000
17:32034909:G:Tacceptor_loss1.0000
17:32034909:GA:Gacceptor_gain1.0000
17:32034909:GAA:Gacceptor_gain1.0000
17:32034909:GAATT:Gacceptor_gain1.0000
17:32034977:TATCT:Tdonor_gain1.0000
17:32034978:ATCT:Adonor_gain1.0000
17:32034979:TCT:Tdonor_gain1.0000
17:32034980:CT:Cdonor_gain1.0000
17:32034981:TGTAA:Tdonor_loss1.0000
17:32034982:G:GAdonor_loss1.0000
17:32034982:G:GGdonor_gain1.0000
17:32034983:TA:Tdonor_loss1.0000
17:32034984:AAGTA:Adonor_loss1.0000
17:32035563:A:AGacceptor_gain1.0000

AlphaMissense

5635 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:32027784:T:AN589K0.982
17:32027784:T:GN589K0.982
17:32024754:T:AW575R0.981
17:32024754:T:CW575R0.981
17:32024756:G:CW575C0.980
17:32024756:G:TW575C0.980
17:32024782:T:CL584P0.980
17:32035639:T:CL708P0.980
17:32031393:T:AN637K0.977
17:32031393:T:GN637K0.977
17:32030671:T:AN613K0.973
17:32030671:T:GN613K0.973
17:32030670:A:TN613I0.970
17:32024726:C:AN565K0.966
17:32024726:C:GN565K0.966
17:32034925:T:AN664K0.964
17:32034925:T:GN664K0.964
17:32022743:T:CC533R0.963
17:32034981:T:CL683P0.963
17:32030699:T:CF623L0.962
17:32030701:T:AF623L0.962
17:32030701:T:GF623L0.962
17:32024716:T:CF562S0.961
17:32022743:T:AC533S0.960
17:32022744:G:CC533S0.960
17:32031421:T:CF647L0.960
17:32031423:T:AF647L0.960
17:32031423:T:GF647L0.960
17:32031392:A:TN637I0.953
17:32027774:T:CL586P0.952

dbSNP variants (sampled 300 via entrez): RS1000179219 (17:32036266 G>GCTA), RS1000240553 (17:32029013 T>A,G), RS1000292902 (17:32029163 AG>A), RS1000621029 (17:32042299 C>T), RS1000636006 (17:32035967 A>G,T), RS1000678193 (17:32042030 T>A,C), RS1000716461 (17:32011303 A>G), RS1000783298 (17:32049943 TTCTC>T,TTC,TTCTCTC), RS1000791158 (17:32017588 T>G), RS1000843611 (17:32017938 G>A,T), RS1000901414 (17:32049789 C>T), RS1001025312 (17:32023391 G>A), RS1001064507 (17:32011051 C>T), RS1001161316 (17:32046096 A>G), RS1001271955 (17:32053430 G>A)

Disease associations

OMIM: gene MIM:616558 | disease phenotypes: MIM:615972, MIM:618786

GenCC curated gene-disease

Mondo (2): nanophthalmos 4 (MONDO:0014426), Imagawa-Matsumoto syndrome (MONDO:0032916)

Orphanet (2): Nanophthalmos (Orphanet:35612), Imagawa-Matsumoto syndrome (Orphanet:659463)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST000817_41Height3.000000e-08
GCST006151_3Memory dysfunction in frontotemporal lobe dementia8.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0001072memory impairment

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

19 total (human), top 19 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases abundance, increases expression2
Valproic Acidaffects expression, decreases expression2
aristolochic acid Iincreases expression1
beta-lapachoneincreases expression1
beta-methylcholineaffects expression1
di-n-butylphosphoric acidaffects expression1
abrineincreases expression1
Air Pollutantsincreases abundance, increases expression1
Arsenicdecreases expression, increases abundance1
Benzo(a)pyreneaffects methylation1
Cisplatinincreases expression1
Doxorubicindecreases expression1
Gallic Acidincreases expression1
Hydrogen Peroxideaffects expression1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1increases expression1
Copper Sulfatedecreases expression1
Lactic Aciddecreases expression1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.